Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Gareri

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Drug Safety - Case Reports|March 5, 2017
Psychomotor Agitation Following Treatment with HydroxychloroquineCiro Manzo, Pietro Gareri, Alberto Castagna
Reviews on Recent Clinical Trials|December 23, 2021
An Overview of Combination Treatment with Citicoline in DementiaPietro Gareri, Nicola Veronese, Antonino Maria Cotroneo
Ageing Research Reviews|June 1, 2002
Neuropharmacology of depression in aging and age-related diseasesPietro Gareri, Pasquale De Fazio, Giovambattista De Sarro
Archives of Gerontology and Geriatrics|May 25, 2020
The CITIMEM study: A pilot study. Optimizing pharmacological treatment in dementiaPietro Gareri, Antonino Maria Cotroneo, Giuseppe Orsitto, et al.
Reviews on Recent Clinical Trials|November 27, 2020
The Importance of Citicoline in Combined Treatment in Dementia: What did the Citimem Study Teach us?Pietro Gareri, Antonino Maria Cotroneo, Giuseppe Orsitto, et al.
Frontiers in Psychology|February 16, 2023
Editorial: Neurocognitive disorders and depression-Complex interrelationshipsKatarzyna Milana Broczek, Marie-Christine Gely-Nargeot, Pietro Gareri
Clinical Drug Investigation|September 3, 2016
The CITIRIVAD Study: CITIcoline plus RIVAstigmine in Elderly Patients Affected with Dementia StudyAlberto Castagna, Antonino Maria Cotroneo, Giovanni Ruotolo, et al.
Frontiers in Psychology|January 6, 2025
Editorial: Depression across cultures and linguistic identitiesKatarzyna Milana Broczek, Marie-Christine Gely-Nargeot, Pietro Gareri
Expert Opinion on Pharmacotherapy|May 17, 2013
An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitorsRoberto Bruzziches, Davide Francomano, Pietro Gareri, et al.
Journal of Alzheimer'S Disease : JAD|June 21, 2024
Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer's DiseasePietro Gareri, Antonino Maria Cotroneo, Roberta Montella, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Drug Safety - Case Reports|March 5, 2017
Psychomotor Agitation Following Treatment with HydroxychloroquineCiro Manzo, Pietro Gareri, Alberto Castagna
Reviews on Recent Clinical Trials|December 23, 2021
An Overview of Combination Treatment with Citicoline in DementiaPietro Gareri, Nicola Veronese, Antonino Maria Cotroneo
Ageing Research Reviews|June 1, 2002
Neuropharmacology of depression in aging and age-related diseasesPietro Gareri, Pasquale De Fazio, Giovambattista De Sarro
Archives of Gerontology and Geriatrics|May 25, 2020
The CITIMEM study: A pilot study. Optimizing pharmacological treatment in dementiaPietro Gareri, Antonino Maria Cotroneo, Giuseppe Orsitto, et al.
Reviews on Recent Clinical Trials|November 27, 2020
The Importance of Citicoline in Combined Treatment in Dementia: What did the Citimem Study Teach us?Pietro Gareri, Antonino Maria Cotroneo, Giuseppe Orsitto, et al.
Frontiers in Psychology|February 16, 2023
Editorial: Neurocognitive disorders and depression-Complex interrelationshipsKatarzyna Milana Broczek, Marie-Christine Gely-Nargeot, Pietro Gareri
Clinical Drug Investigation|September 3, 2016
The CITIRIVAD Study: CITIcoline plus RIVAstigmine in Elderly Patients Affected with Dementia StudyAlberto Castagna, Antonino Maria Cotroneo, Giovanni Ruotolo, et al.
Frontiers in Psychology|January 6, 2025
Editorial: Depression across cultures and linguistic identitiesKatarzyna Milana Broczek, Marie-Christine Gely-Nargeot, Pietro Gareri
Expert Opinion on Pharmacotherapy|May 17, 2013
An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitorsRoberto Bruzziches, Davide Francomano, Pietro Gareri, et al.
Journal of Alzheimer'S Disease : JAD|June 21, 2024
Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer's DiseasePietro Gareri, Antonino Maria Cotroneo, Roberta Montella, et al.
Pageof 8